Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (TFPB) anion was highly lipophilic, practically insoluble in water, and durable against acid and oxidants. Partition equilibria of alkali TFPB between water and organic solvents and the stability in acid media are described and compared with the properties of the parent tetraphenylborate and of some fluorine-containing homologues.
Remarkable accerelation was observed by use of sodium tetrakis[3,5-di(F-methyl)phenyl]borate as a negatively charged phase transfer catalyst for diazonium ion in the azo coupling reactions of aryldiazonium tetrafluoroborate with a range of diazophile components in liquid–liquid- and liquid–solid two-phase systems. Kinetics of the reactions was examined to confirm the phase transfer catalysis.
Anion-catalyzed phase-transfer catalysis was evidenced in the diazo-coupling reactions of the arenediazonium ion with a range of diazophile components in liquid-liquid- and liquid-solid two-phase systems. The tetrakis[3,5-bis(trifluoromethyl)phenyl]borate ion was effective as an anionic catalyst to accelerate the reactions. Comparisons of the reaction rates in the two-phase system with those in solution systems indicated that the acceleration was due to the increased activity of the cationic reagent, partly by solubilization and partly by the dehydration of such cationic species in the nonpolar organic phase.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.